Cortexyme () P/E US GAAP (year values) |
||||||||
2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | |||
P/E | ? | 0.00 | 0.00 | -28.9 | -10.5 | -4.18 | -480.7 | |
Changes by years, y/y, % | -64% | -60% |
Cortexyme. P/E
Cortexyme. P/E, changes, %
Cortexyme () P/E US GAAP (quarter values) |
||||||||
2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
P/E | ? | -18.0 | -31.3 | -2.40 | -1.20 | -480.7 | -480.7 | |
Changes by years, y/y, % | -25% | +46% | -77% | -91% | +2 564% | |||
Changes by quarters, q/q, % | +40% | +74% | -92% | -50% | +39 878% |